| HOME >> MEDICINE >> TECHNOLOGY |
(6)
(9)19
(5)Income (loss) before income taxes
158
119431
(1,455)Income tax expense
12
21239
36Net income (loss)$
46$
98$
92$ (1,491)Net income (loss) per common share - basic$
.10$
.06$
.12$
(0.98)Net income (loss) per common share - assuming dilution$
.10$
.06$
.12$
(0.98)Weighted-average shares outstandingBasic
1,528.6
1,516.61,527.5
1,515.6Assuming dilution
1,535.8
1,525.31,536.0
1,515.6BOSTON SCIENTIFIC CORPORATIONCONDENSED CONSOLIDATED BALANCE SHEETSAs ofJune 30,December 31,in millions, except share data
20112010(Unaudited)ASSETSCurrent assets:Cash and cash equivalents
$
54$
213Trade accounts receivable, net
1,3341,320Inventories
927894Deferred income taxes
417429Assets held for sale
7576Prepaid expenses and other current assets
310183Total current assets
3,1493,615Property, plant and equipment, net
1,7021,697Goodwill
9,75810,186Other intangible assets, net
6,6846,343Other long-term assets
266287$ 21,559$
22,128LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Current debt obligations
$
4$
504Accounts payable
223184Accrued expenses
1,3291,626Other current liabilities
336295Total current liabilities
1,8922,609Long-term debt
4,1974,934Deferred income taxes
1,9161,644Other long-term liabilities
2,0141,645Commitments and contingenciesStockholders' equityPreferred stock, $.01 par value - authorized 50,000,000shares, none issued and outstandingCommon stock, $.01 par value - authorized 2,000,000,000shares, issued 1,528,799,782 shares as of June 30, 2011 and
15151,520,780,112 shares as of December 31, 2010Additional paid-in capital
16,27816,232Accumulated deficit
(4,630)(4,822)Other stockholders' deficit
(1
'/>"/>
| SOURCE Boston Scientific Corporation Copyright©2010 PR Newswire. All rights reserved |